Myoview (Tc-99m tetrofosmin) is a vital imaging agent to assess myocardial perfusion in diagnostic nuclear medicine procedures, particularly single-photon emission computed tomography (SPECT). GE Healthcare developed it and has been in use since the 1990s. Myoview is primarily used to detect coronary artery disease (CAD), evaluate myocardial viability, and sometimes assess ventricular function.
Myoview is a lipophilic cationic complex that contains the radionuclide technetium-99m (Tc-99m). Tc-99m is a gamma-emitting isotope with a relatively short half-life of 6 hours, making it an ideal choice for nuclear medicine imaging. In addition, the Tc-99m tetrofosmin complex is specifically designed to mimic the physicochemical properties of naturally occurring molecules in the myocardium, such as potassium. As a result, it can be taken up by the myocardial cells via the exact membrane transport mechanisms.
During a Myoview SPECT scan, the patient is injected with the Myoview radiotracer. The tracer is taken up by the heart muscle cells in proportion to blood flow, allowing for the identification of areas with reduced blood flow. By performing the scan under both resting and stress conditions, clinicians can assess the presence and severity of CAD. The stress phase typically involves either physical exercise or the administration of a pharmacologic stress agent, which simulates the effect of exercise on the heart.
The Myoview SPECT scan produces high-resolution images of the heart that can be analysed to evaluate myocardial perfusion. Areas with reduced tracer uptake indicate ischemic or infarcted tissue, which may result from a blocked or narrowed coronary artery. Consequently, the Myoview SPECT scan is instrumental in identifying the presence of CAD and determining the necessity for further interventions, such as angioplasty or bypass surgery.
One of the key advantages of Myoview is its rapid clearance from the bloodstream, which reduces background noise and enhances image quality. Additionally, the agent has a low radiation dose, minimising the risk of radiation exposure for patients undergoing the procedure. The Myoview SPECT scan is also relatively safe, with few reported side effects. Some patients may experience mild reactions such as headache, dizziness, or nausea, but these are generally short-lived and resolve without intervention.
You are here:
home »
The Fundamentals and Importance of SPECT Imaging Medical imaging has revolutionised how we diagnose and monitor diseases, providing invaluable insights […]
SPECT Imaging: Insights into Modern Medical Diagnostics Read Post »
Technetium-99m tetrofosmin is vital for detecting coronary artery disease via myocardial perfusion imaging, enhancing cardiac care.
Technetium-99m Sestamibi revolutionises cardiac care by precisely mapping blood flow in diagnosing coronary artery disease.
Nitrogen-13 Ammonia, used in cardiac PET imaging, assesses myocardial perfusion, aiding diagnosis and treatment of heart diseases.
Exploring Nitrogen-13 Ammonia: A Vital Radiotracer in Cardiac Imaging and Beyond Read Post »
Heart imaging provides non-invasive ways to diagnose, treat, and monitor heart disease for better outcomes.
Medical Imaging of the Heart: From Diagnosis to Treatment Read Post »
